CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- S-3 Offering Registration Statement
- 8-K Event Material agreement
- 8-K Event Material agreement · Unregistered share sale · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Shareholder vote results
- 4 Insider Changes in Ownership
- DEFA14A Proxy Proxy Materials
- 8-K Event Auditor change
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 3 of 64 · 1,274 filings